|
Teva Challenges AstraZeneca's Patent on Blockbuster Seroquel
Teva Pharmaceutical has filed an abbreviated new drug application (ANDA) to market a generic version of AstraZeneca’s schizophrenia treatment Seroquel, one of two drugs key to AstraZeneca’s future growth after several recent setbacks. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives